about
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskComplete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient miceHIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexinAn apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.Characteristics and functional relevance of apolipoprotein-A1 and cholesterol binding in mammary gland tissues and epithelial cellsLDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages.HIV infection induces structural and functional changes in high density lipoproteins.Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.Prion infection impairs cholesterol metabolism in neuronal cells.Quercetin improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice fed a high-fat diet.Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisBilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression.Genome-Edited Human Pluripotent Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport--Brief Report.HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells.Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT mouse model of preeclampsia
P2860
Q26775420-09E562F8-3FB1-44B3-A748-49C3900B2564Q33867669-B08A92C0-94C5-47D0-8B98-DECDF3A22778Q34355599-D7763553-AA18-4372-890F-29DB2766492CQ34851167-8AD9B554-D56E-42A4-AEE2-241AED0BF098Q34922789-B2C10432-8777-4FF9-B2AB-662DBABAE108Q35659751-54070180-E95C-47F4-89E3-880B5E6A7273Q36173726-EBEB192B-D3D5-4C3A-B5CF-D21C280BAB1DQ37038670-71D27DD1-A9C4-40F4-9319-B20E3A9F980EQ37459299-1712F264-25EC-460B-9340-EE1F88378703Q37587110-A736E027-1347-49A4-8C0F-0235253AEEB4Q37609624-DE4F304E-DF3F-431C-82B8-7705801B8D97Q38813542-573072E4-34C6-4AD2-9962-BAD367F1F378Q38821617-C5B174CF-211D-4164-A6AA-74E281B70FBCQ47761129-94EC0CEB-30D1-4672-B89A-A5E6451BE0B3Q52653326-F9CE8E6D-1A8B-4276-A0FF-A2A35DF101F0Q58737878-18851212-AE68-43F0-AC24-533473C6938C
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cholesterol efflux assay.
@ast
Cholesterol efflux assay.
@en
type
label
Cholesterol efflux assay.
@ast
Cholesterol efflux assay.
@en
prefLabel
Cholesterol efflux assay.
@ast
Cholesterol efflux assay.
@en
P2093
P2860
P356
P1476
Cholesterol efflux assay.
@en
P2093
Dmitri Sviridov
P2860
P356
10.3791/3810
P577
2012-03-06T00:00:00Z